21 November 2019	AH: Heidelberg Pharma Participates in Franco-German Joint Venture Emergence Therapeutics and Signs Collaboration and License Agreement	PDF	Read More
12 November 2019	AH: Partner Magenta Therapeutics Exercises Option to Further Develop Antibody Targeted Amanitin Conjugates Targeted to CD45	PDF	Read More
07 November 2019	PR: Heidelberg Pharma Announces Participation at Various Conferences	PDF	Read More
26 October 2019	PM: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2019	PDF	Read More
11 October 2019	PM: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2019	PDF	Read More
03 October 2019	AH: Heidelberg Pharma AG Announces Adjustment of Guidance	PDF	Read More
20 September 2019	PR: Heidelberg Pharma receives European Union research grant for the ETN MAGICBULLET project	PDF	Read More
12 July 2019	PR: Heidelberg Pharma reports on first half-year	PDF	Read More
12 June 2019	PR: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences	PDF	Read More
06 June 2019	PR: Heidelberg Pharma Receives Milestone Payment from Partner Telix	PDF	Read More
22 May 2019	PR: Heidelberg Pharma Reports Outcome Of Annual General Meeting	PDF	Read More
12 April 2019	PR: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2019	PDF	Read More
28 March 2019	PR: Heidelberg Pharma to present its proprietary ATAC technology platform at the AACR Annual Meeting 2019	PDF	Read More
21 March 2019	PR: Heidelberg Pharma announces financial figures for fiscal year 2018 and provides business update	PDF	Read More
23 January 2019	PR: Heidelberg Pharma Receives Milestone Payment From Partner Link Health	PDF	Read More
02 November 2018	PM: Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2018	PDF	Read More
11 October 2018	PR: Heidelberg Pharma AG: Interim management statement on the first nine months of 2018	PDF	Read More
11 October 2018	AH: Partner Magenta Therapeutics Exercises Option To Further Develop a Target Molecule as Antibody Targeted Amanitin Conjugate	PDF	Read More
23 August 2018	PR: Heidelberg Pharma AG: Partner Telix Pharmaceuticals Files Phase III Trial for Kidney Cancer Imaging in Europe	PDF	Read More
12 July 2018	PR: Heidelberg Pharma reports on first half-year	PDF	Read More
26 June 2018	PR: Heidelberg Pharma Reports Outcome Of Annual General Meeting	PDF	Read More
30 April 2018	PR: Heidelberg Pharma Presents at Upcoming Conferences and Investor Events	PDF	Read More
12 April 2018	Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2018	PDF	Read More
09 April 2018	PM: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences	PDF	Read More
22 March 2018	PM: Heidelberg Pharma announces financial figures for fiscal year 2017 and provides business update	PDF	Read More
05 March 2018	AH: Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement for the Development of Antibody Drug Conjugates	PDF	Read More
05 March 2018	PR: Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement for the Development of Antibody Drug Conjugates	PDF	Read More
01 March 2018	PR: Heidelberg Pharma Signs License Agreement with The University of Texas MD Anderson Cancer Center	PDF	Read More
08 January 2018	PR: Heidelberg Pharma AG and Advanced Proteome Therapeutics Progress Collaborative Program	PDF	Read More
21 November 2017	AH: Heidelberg Pharma AG raises approximately EUR 34.4 million from capital measure	PDF	Read More

Press Releases and Ad-hoc Announcements